Work

A Phase 2 Study Of Brentuximab Vedotin In Patients With Relapsed Or Refractory CD30-Positive Non-Hodgkin Lymphomas: Interim Results In Patients With DLBCL and Other B-Cell Lymphomas

Year: 2013

Type: article

Source: Blood

DOI: 10.1182/blood.v122.21.848.848

Authors: Nancy L. Bartlett, Jeff P. Sharman, Yasuhiro Oki, Ranjana H. Advani, Celeste M. Bello, Jane N. Winter, Yin Yang, Dana A. Kennedy, Eric D. Jacobsen

Institutions: Washington University in St. Louis, Willamette Valley Cancer Institute and Research Center, The University of Texas MD Anderson Cancer Center, Stanford Medicine, Moffitt Cancer Center, Northwestern University, Seagen (United States), Dana-Farber Cancer Institute

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2286803867

FWCI: 8.227

Cites:

Cited by: 49

Related to: 10